DoD Pancreatic Cancer, Translational Research Partnership Award
The summary for the DoD Pancreatic Cancer, Translational Research Partnership Award grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.
DoD Pancreatic Cancer, Translational Research Partnership Award: The FY20 PCARP Translational Research Partnership Award supports partnerships between clinicians and research scientists that will accelerate the movement of promising ideas in pancreatic cancer toward clinical applications. This award supports the development of translational research collaborations between two independent investigators to address a central problem or question in pancreatic cancer in a manner that would be less readily achievable through separate efforts. One partner in the collaboration must function as a research scientist and the other partner as a clinician investigator. It should be clear that both have had equal intellectual input in the design of the research project. Multi-institutional and multi-discipline partnerships are strongly encouraged. At least one partner must have expertise either in pancreatic cancer research or pancreatic cancer patient care. Inclusion of experts from outside the pancreatic cancer field is encouraged. A proposed project in which the clinical partner merely supplies tissue samples or access to patients will not meet the intent of this award mechanism. Full support for large scale clinical trials is not expected; retrospective tissue analysis, correlative studies, or small pilot clinical trials are permitted.Significant features of the Translational Research Partnership Award: · Partnership: The success of the project should depend on the unique skills and contributions of each partner. · Translation: The application should provide evidence for the reciprocal transfer of information between basic and clinical science, or vice versa, in developing and implementing the research plan. Translational research may include correlative studies and/or development of or use of annotated biorepositories. The application should demonstrate how the study will leverage clinical information to address knowledge gaps in resulting outcomes, validate key research findings, expand upon potentially transformative results, and/or investigate novel findings. · Impact: The proposed research should indicate the potential to have a significant impact on pancreatic cancer research and/or patient care and have the potential to accelerate the movement of promising ideas (in prevention, diagnosis, detection, prognosis, treatment, and/or survivorship) into clinical applications. · Feasibility: The application should demonstrate that the investigators have access to the necessary specimens, data, and/or intervention, as applicable. · Preliminary Data: Unpublished results from the laboratory of the PIs or collaborators named on the application that are relevant to pancreatic cancer and the proposed research project, are required.
Federal Grant Title: | DoD Pancreatic Cancer, Translational Research Partnership Award |
Federal Agency Name: | Dept of the Army USAMRAA (DOD-AMRAA) |
Grant Categories: | Science and Technology |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | W81XWH-20-PCARP-TRPA |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 12.420 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | December 10th, 2020 |
Original Application Deadline: | December 10th, 2020 |
Posted Date: | July 1st, 2020 |
Creation Date: | July 1st, 2020 |
Archive Date: | January 9th, 2021 |
Total Program Funding: | $2,400,000 |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | 2 |
Cost Sharing or Matching: | No |
Last Updated: | September 8th, 2020 |
- Applicants Eligible for this Grant
- Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
- Grant Announcement Contact
- CDMRP Help Desk
Phone: 301-682-5507
Email: [email protected]
CDMRP Help Desk - Similar Government Grants
- • DoD Tick-Borne Disease, Idea Development Award
- • DoD Tick-Borne Disease, Therapeutic/Diagnostic Research Award
- • DoD Rare Cancers, Concept Award
- • DoD Multiple Sclerosis, Early Investigator Research Award
- • DoD Rare Cancers, Idea Development Award
- • FY2006 Deployed War Fighter Protection Research Program
- • Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)C...
- • Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) ...
- More Grants from the Dept of the Army USAMRAA
- • DoD Rare Cancers, Concept Award
- • DoD Tuberous Sclerosis Complex, Clinical Translational Research Award
- • DoD Tuberous Sclerosis Complex, Exploration-Hypothesis Development Award